PTEN and neoplasm: On the molecular level, more than 80% type I tumours are associated with a decreased or lacking expression of Phosphatase and tensin homolog (PTEN) and to an overexpressed Oestrogen Receptor (ER), which promote a deregulated cellular proliferation [37,38,39,40].